Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | MMP14 | P50281 | 1/20 | 0.32 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.31 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21037280 | 0.89 | APP (0.38) | ALDH1A1KMT2AMEN1RPS6KA3ATM | |
| SCHEMBL21234685 | 0.85 | APP (0.43) | ALDH1A1KMT2AMEN1RPS6KA3APP | |
| SCHEMBL21037326 | 0.82 | RPS6KA3 (0.36) | ALDH1A1KMT2AMEN1RPS6KA3SLC16A3 | |
| SCHEMBL21160458 | 0.80 | ALDH1A1 (0.36) | ALDH1A1KMT2AMEN1RPS6KA3SLC16A3 | |
| SCHEMBL21160428 | 0.79 | ALDH1A1 (0.36) | ALDH1A1KMT2AMEN1RPS6KA3SLC16A3 | |
| SCHEMBL21160422 | 0.77 | MMP14 (0.40) | MMP14TMPRSS15 | |
| SCHEMBL22313935 | 0.77 | APP (0.41) | SLC16A3SLC16A1APPMAPT | |
| SCHEMBL21037324 | 0.77 | ALDH1A1 (0.33) | ALDH1A1KMT2AMEN1RPS6KA3SLC16A3 | |
| SCHEMBL21037880 | 0.76 | MEN1 (0.34) | ALDH1A1KMT2AMEN1RPS6KA3 | |
| SCHEMBL21037850 | 0.74 | MEN1 (0.46) | ALDH1A1KMT2AMEN1MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) | 2021-12-28 | — | — | US | disclosed |
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | HNRNPF, HNRNPUL2, RAB5IF | ALDH1A1 3152/4885KMT2A 4751/4885MEN1 2099/4885 |
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | HNRNPF, HNRNPUL2, RAB5IF | ALDH1A1 3152/4885KMT2A 4751/4885MEN1 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.